🚨 New Releases 🚨
Toxic Exposures: Examining the Implications of Current Screening Guidelines, the PACT Act, and Early Detection Opportunities
Start watching
Leveraging Natural Language Processing to Capture Incidental Pulmonary Nodules: A Health Systems Approach
Start watching
Innovative Approaches to Customizing Multidisciplinary Team Collaboration in All Settings
Start watching
Evidence Based Management of Incidental Findings in Screening for Optimal Patient Outcome and Program
Start watching
Emerging Therapies in Small Cell Lung Cancer
Start watching
All Courses
GO2 for Lung Cancer Support Programs
GO2 Support Programs are designed to support those at risk for or diagnosed with lung cancer and their loved ones.
Inspiring Excellence Near Home: Addressing Access and Quality Lung Cancer Care for Sexual and Gendered Minorities, and People Living with Serious Mental Illness
This thought-provoking and motivating session with Sam McClure and Elyse Park delves into the impact of lung cancer on two key populations—sexual and gendered minorities and people living with severe mental illness.
The Lung Cancer Disparity in Women: Is It Different?
Dr. Narjust Florez shares her research that tells an all too common and intimate lung cancer story about diagnosis delays, treatment biases, financial toxicity, stigma, and the reality of reproductive and sexual health in women.
Lung Cancer in Women: A Hidden Health Disparity
Listen in on thoracic surgeon Dr. Jeffrey Velottas informative deep dive into this well-established and troubling trend in Asian women.
Exploring the Data and Value of Smoking Cessation in the Therapeutic Management of Lung Cancer
Dr. Graham Warren brings to bear what everyone working to help prevent, screen, treat, and research lung cancer should know about the biologic, clinical, and economic effects and outcomes.
Lung Cancer 2023: Targeted Therapies - Precision Medicine at Its Finest
Dr. Levy discusses the criticality of biomarker testing in precision oncology and targeted therapies to improve lung cancer outcomes.
Crossing the Chasm of Disparities and Health Equity of Lung Cancer in Our Communities: A Call to Action
Dr. Williams discusses the starkly distinct health disparities and inequities in lung cancer, which have deeply impacted the Black community.
Safe and Responsible Detection, Reporting, Tracking, and Management of Pulmonary Nodules
Capturing and characterizing pulmonary nodules are just the tip of the iceberg in lung cancer detection. This activity will discuss guideline-directed management of pulmonary nodules and the role of the multidisciplinary team in this endeavor.
Diagnostic Workup of Pulmonary Nodules
Incidental pulmonary nodule detection is common, but most are not cancer. This activity will summarize the various approaches to diagnostic workup for a tissue diagnosis and discuss the clinical indications, limitations, and potential risks of each.
Artificial Intelligence in Pulmonary Nodule Management – A Practical Guide
Artificial Intelligence has piqued the interest of the healthcare community. This activity will discuss machine learning, its powerful algorithms and modeling that can assist clinicians in managing pulmonary nodules, and the pros and cons of its use.
Determination of Malignancy Risk of Incidental Pulmonary Nodules
Incidental pulmonary nodules can represent a broad range of underlying conditions. This activity uses cases to illustrate methodological approaches to risk assessment and stratification of nodules, determining the pretest probability for malignancy.
Building an Incidental Pulmonary Nodule Program
Efficient and effective capture of incidental pulmonary nodules depends on a well-structured clinical program. This activity will cover various topics that support administrators, clinicians, and support staff in developing highly effective programs.
Surgical Management of Incidental Pulmonary Nodules
Surgery should be considered for pulmonary nodules that are concerning for malignancy. This activity will discuss the evaluation of suspicious nodules, including common approaches to surgical resection and alternatives to surgery.
Incidental Pulmonary Nodules 101
Timely identification of incidental pulmonary nodules (IPNs) is an opportunity for early lung cancer detection. This activity offers a case-based introduction to IPNs, differential diagnosis, and malignancy risk prediction modeling.
Braidwood v. Becerra: Background and Implications on the ACA’s No Cost-Sharing Provision
Updated August 2024: Explore the federal court case Braidwood v. Becerra and its implications on the Affordable Care Act (ACA) in this detailed video.
Survivorship in Transition
With patients living longer and with a higher quality of life, how are we helping them transition from oncology to wellness.
Patient Engagement Pathways for Population Impact in Screening
This session will explore multiple patient engagement on-ramps to build awareness, grow uptake, drive adherence, and reduce disparities.
Leveraging Mammograms to Reach At Risk Women for Lung Cancer Early Detection
Harnessing mammography to identify, educate, refer and screen at-risk women for lung cancer.
State-Based Strategies to Strengthen Reach and Impact
This course explores successes in state-focused collaborative efforts to identify, develop, and implement strategies that improve access, uptake, and impact in lung cancer screening.
The Role of Cessation in Patient-Centered Care Across the Screening and Care Continuum
This course addresses the vital role and impact of cessation integration within evidence-based lung cancer care, from screening through the post-diagnosis care continuum. Particular attention is paid to empathetic approaches in cessation referral
How Healthcare Professionals May Be Stigmatizing People with Lung Cancer and What You Can Do About It
This course will provide examples of stigmatizing interactions between patients and healthcare professionals, review new data showing that stigma continues to be a problem at a national level, and provide practical tips for your interactions.
What Do You See on a Chest LDCT? An Introductory Primer on LDCT Chest Images for the Non-Radiologist
This course provides screening navigators and coordinators — particularly those with a non-thoracic background — with an introduction to chest LDCT scan images, to help them better understand image interpretation and more effectively communicate.
Access, Equity and Quality: Breaking the Cycle for Vulnerable Populations
Presented at 2022 Summit!
In this course Dr. Christopher Slatore will identify the disparities of vulnerable lung cancer populations. Also explore ways to advocate on increasing access, equity and quality.
Building Access for the New USPSTF Screening Population
Learn about the Updated 2021 USPSTF Lung Cancer Screening Recommendations
Racial Disparities in the Surgical Treatment of Early-Stage Non-Small Cell Lung Cancer
Presented at 2022 Summit!
In the course Dr. Elizabeth David will focus on the racial disparities and treatment of early non-small cell lung cancer.
COE Summit 2023
Inspiring Excellence Near Home: Addressing Access and Quality Lung Cancer Care for Sexual and Gendered Minorities, and People Living with Serious Mental Illness
This thought-provoking and motivating session with Sam McClure and Elyse Park delves into the impact of lung cancer on two key populations—sexual and gendered minorities and people living with severe mental illness.
The Lung Cancer Disparity in Women: Is It Different?
Dr. Narjust Florez shares her research that tells an all too common and intimate lung cancer story about diagnosis delays, treatment biases, financial toxicity, stigma, and the reality of reproductive and sexual health in women.
Lung Cancer in Women: A Hidden Health Disparity
Listen in on thoracic surgeon Dr. Jeffrey Velottas informative deep dive into this well-established and troubling trend in Asian women.
Exploring the Data and Value of Smoking Cessation in the Therapeutic Management of Lung Cancer
Dr. Graham Warren brings to bear what everyone working to help prevent, screen, treat, and research lung cancer should know about the biologic, clinical, and economic effects and outcomes.
Lung Cancer 2023: Targeted Therapies - Precision Medicine at Its Finest
Dr. Levy discusses the criticality of biomarker testing in precision oncology and targeted therapies to improve lung cancer outcomes.
Crossing the Chasm of Disparities and Health Equity of Lung Cancer in Our Communities: A Call to Action
Dr. Williams discusses the starkly distinct health disparities and inequities in lung cancer, which have deeply impacted the Black community.
CME/CE Credit
Safe and Responsible Detection, Reporting, Tracking, and Management of Pulmonary Nodules
Capturing and characterizing pulmonary nodules are just the tip of the iceberg in lung cancer detection. This activity will discuss guideline-directed management of pulmonary nodules and the role of the multidisciplinary team in this endeavor.
Diagnostic Workup of Pulmonary Nodules
Incidental pulmonary nodule detection is common, but most are not cancer. This activity will summarize the various approaches to diagnostic workup for a tissue diagnosis and discuss the clinical indications, limitations, and potential risks of each.
Artificial Intelligence in Pulmonary Nodule Management – A Practical Guide
Artificial Intelligence has piqued the interest of the healthcare community. This activity will discuss machine learning, its powerful algorithms and modeling that can assist clinicians in managing pulmonary nodules, and the pros and cons of its use.
Determination of Malignancy Risk of Incidental Pulmonary Nodules
Incidental pulmonary nodules can represent a broad range of underlying conditions. This activity uses cases to illustrate methodological approaches to risk assessment and stratification of nodules, determining the pretest probability for malignancy.
Building an Incidental Pulmonary Nodule Program
Efficient and effective capture of incidental pulmonary nodules depends on a well-structured clinical program. This activity will cover various topics that support administrators, clinicians, and support staff in developing highly effective programs.
Surgical Management of Incidental Pulmonary Nodules
Surgery should be considered for pulmonary nodules that are concerning for malignancy. This activity will discuss the evaluation of suspicious nodules, including common approaches to surgical resection and alternatives to surgery.
Incidental Pulmonary Nodules 101
Timely identification of incidental pulmonary nodules (IPNs) is an opportunity for early lung cancer detection. This activity offers a case-based introduction to IPNs, differential diagnosis, and malignancy risk prediction modeling.
Incidental Pulmonary Nodules
Safe and Responsible Detection, Reporting, Tracking, and Management of Pulmonary Nodules
Capturing and characterizing pulmonary nodules are just the tip of the iceberg in lung cancer detection. This activity will discuss guideline-directed management of pulmonary nodules and the role of the multidisciplinary team in this endeavor.
Diagnostic Workup of Pulmonary Nodules
Incidental pulmonary nodule detection is common, but most are not cancer. This activity will summarize the various approaches to diagnostic workup for a tissue diagnosis and discuss the clinical indications, limitations, and potential risks of each.
Artificial Intelligence in Pulmonary Nodule Management – A Practical Guide
Artificial Intelligence has piqued the interest of the healthcare community. This activity will discuss machine learning, its powerful algorithms and modeling that can assist clinicians in managing pulmonary nodules, and the pros and cons of its use.
Determination of Malignancy Risk of Incidental Pulmonary Nodules
Incidental pulmonary nodules can represent a broad range of underlying conditions. This activity uses cases to illustrate methodological approaches to risk assessment and stratification of nodules, determining the pretest probability for malignancy.
Building an Incidental Pulmonary Nodule Program
Efficient and effective capture of incidental pulmonary nodules depends on a well-structured clinical program. This activity will cover various topics that support administrators, clinicians, and support staff in developing highly effective programs.
Surgical Management of Incidental Pulmonary Nodules
Surgery should be considered for pulmonary nodules that are concerning for malignancy. This activity will discuss the evaluation of suspicious nodules, including common approaches to surgical resection and alternatives to surgery.
Incidental Pulmonary Nodules 101
Timely identification of incidental pulmonary nodules (IPNs) is an opportunity for early lung cancer detection. This activity offers a case-based introduction to IPNs, differential diagnosis, and malignancy risk prediction modeling.
Screening
Patient Engagement Pathways for Population Impact in Screening
This session will explore multiple patient engagement on-ramps to build awareness, grow uptake, drive adherence, and reduce disparities.
State-Based Strategies to Strengthen Reach and Impact
This course explores successes in state-focused collaborative efforts to identify, develop, and implement strategies that improve access, uptake, and impact in lung cancer screening.
The Role of Cessation in Patient-Centered Care Across the Screening and Care Continuum
This course addresses the vital role and impact of cessation integration within evidence-based lung cancer care, from screening through the post-diagnosis care continuum. Particular attention is paid to empathetic approaches in cessation referral
What Do You See on a Chest LDCT? An Introductory Primer on LDCT Chest Images for the Non-Radiologist
This course provides screening navigators and coordinators — particularly those with a non-thoracic background — with an introduction to chest LDCT scan images, to help them better understand image interpretation and more effectively communicate.
Building Access for the New USPSTF Screening Population
Learn about the Updated 2021 USPSTF Lung Cancer Screening Recommendations